Immunohistochemical analysis of hMLH1 and hMSH2 proteins in serous ovarian tumours

Polish Journal of Pathology

Volumn 60, Issue 4, 2009, Pages 174-178

  Stasikowska Kanicka, Olga ^a   Stawerski, Paweł ^a   Wagrowska Danilewicz, Małgorzata ^a   Da̧nilewicz, Marian ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

hMLH1; hMSH2; Serous ovarian tumours

Indexed keywords

MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; NUCLEAR PROTEIN; PROTEIN MSH2; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; AGED; ARTICLE; EVALUATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MIDDLE AGED; MUTATION; NEOPLASM; OVARY TUMOR; PATHOLOGY; RETROSPECTIVE STUDY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUTATION; MUTS HOMOLOG 2 PROTEIN; NEOPLASMS, CYSTIC, MUCINOUS, AND SEROUS; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 77951646906     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics 2009. CA Cancer J Clin 2009; 59: 225-249.
2. Ferla R, Calo V, Cascio S, et al. Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol 2007; 18: 93-98.
3. Ratajska M, Brozek I, Senkus-Konefka E, et al. BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland. Oncol Rep 2008; 19: 263-268.
4. Kolas NK, Cohen PE. Novel and diverse functions of the DNA mismatch repair family in mammalian meiosis and recombination. Cytogenet Genome Res 2004; 107: 216-231.
5. Laghi L, Bianchi P, Malesci A. Differences and evolution of the methods for the assessment of microsatellite instability. Oncogene 2008; 27: 6313-6321.
6. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58: 5248-5257.
7. Brown GJ, St John DJ, Macrae FA, Aittomaki. Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance. Gynecol Oncol 2001; 80: 346-349.
8. Cai KQ, Albarracin C, Rosen D, et al. Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma. Hum Pathol 2004; 35: 552-559.
9. Marcus VA, Madlensky L, Gryfe R, et al. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 1999; 23: 1248-1255.
10. Plevová P, Krepelová A, Papezová M, et al. Immunohistochemical detection of the hMLH1 and hMSH2 proteins in hereditary non-polyposis colon cancer and sporadic colon cancer. Neoplasma 2004; 51: 275-284.
11. Thibodeau SN, French AJ, Roche PC, et al. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 1996; 56: 4836-4840.
12. Geyer JT, López-García MA, Sánchez-Estevez C, et al. Pathogenetic pathways in ovarian endometrioid adenocarcinoma: a molecular study of 29 cases. Am J Surg Pathol 2009; 33: 1157-1163.
13. Plisiecka-Hałasa J, Dansonka-Mieszkowska A, Kraszewska E, et al. Loss of heterozygosity, microsatellite instability and TP53 gene status in ovarian carcinomas. Anticancer Res 2008; 28: 989-996.
14. Shen XJ, Ali-Fehmi R, Weng CR, et al. Loss of heterozygosity and microsatellite instability at the Xq28 and the A/G heterozygosity of the QM gene are associated with ovarian cancer. Cancer Biol Ther 2006; 5: 523-528.
15. Allen HJ, DiCioccio RA, Hohmann P, et al. Microsatellite instability in ovarian and other pelvic carcinomas. Cancer Genet Cytogenet 2000; 117: 163-166.
16. Fujita M, Enomoto T, Yoshino K, et al. Microsatellite instability and alterations in the hMSH2 gene in human ovarian cancer. Int J Cancer 1995; 64: 361-366.
17. Gras E, Catasus L, Arguelles R, et al. Microsatellite instability, MLH-1 promoter hyper-methylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors. Cancer 2001; 92: 2829-2836.
18. King BL, Carcangiu ML, Carter D, et al. Microsatellite instability in ovarian neoplasms. Br J Cancer 1995; 72: 376-382.
19. Krajinovic M, Richer C, Gorska-Flipot I, et al. Genomic loci susceptible to replication errors in cancer cells. Br J Cancer 1998; 78: 981-985.
20. Ohwada M, Suzuki M, Saga Y, Sato I. DNA replication errors are frequent in mucinous cystadenocarcinoma of the ovary. Cancer Genet Cytogenet 2000; 117: 61-65.
21. Helleman J, van Staveren IL, Dinjens WN, et al. Mismatch repair and treatment resistance in ovarian cancer. BMC Cancer 2006; 31: 201.
22. Haas CJ, Diebold J, Hirschmann A, et al. Microsatellite analysis in serous tumors of the ovary. Int J Gynecol Pathol 1999; 18: 158-162.
23. Yoon BS, Kim YT, Kim JH, et al. Clinical significance of microsatellite instability in sporadic epithelial ovarian tumors. Yonsei Med J 2008; 49: 272-278.
24. Giarnieri E, Mancini R, Pisani T, et al. Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix. Clin Cancer Res 2000; 6: 3600-3606.
25. Wolf NG, Abdul-Karim FW, Farver C, et al. Analysis of ovarian borderline tumors using comparative genomic hybridization and fluorescence in situ hybridization. Genes Chromosomes Cancer 1999; 25: 307-315.
26. Wolf NG, Farver C, Abdul-Karim FW, Schwartz S. Analysis of microsatellite instability and X-inactivation in ovarian borderline tumors lacking numerical abnormalities by comparative genomic hybridization. Cancer Genet Cytogenet 2003; 145: 133-138.